S004 Hot Topics
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The symposium will address those 'hot topics' established by registrant consensus, a true reflection of member concerns and interests. The session will be a 'potpourri' of medical/surgical topics, including some with social and economic import. Expert speakers will provide 'state of the art' material, highlighting recent trends and developments and accenting emerging and innovative therapies. Presentations will be derm relevant, clinically germane, and directly applicable to patient care.
LEARNING OBJECTIVES
Diagnose skin diseases more effectively.
Recognize the medical/surgical implications of those entities, including diagnosis and treatment, especially emerging and innovative therapies.
Apply evolving evidence-based knowledge to patient care.
SCHEDULE
5:00 PM
Welcome/Introduction
Kenneth J. Tomecki, MD, FAAD
5:05 PM
Acne: What's New
Andrea L. Zaenglein, MD, FAAD
5:30 PM
Hairy Matters: What's New in Alopecia
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
5:55 PM
Cosmeceuticals: Naturally Absurd
Cheri Frey, MD, FAAD
6:20 PM
Atopic Dermatitis: New Developments
Emma Guttman, MD, PhD, FAAD
6:45 PM
Biologics and Psoriasis: the Beat Goes On
Joseph Merola, MD, MSc, FAAD
7:10 PM
Melanoma Update
Allan C. Halpern, MD, FAAD
7:35 PM
What’s New in Derm Surgery
Anthony V. Benedetto, DO, FAAD
SPEAKERS
Anthony V. Benedetto, DO, FAAD
Cheri Frey, MD, FAAD
Emma Guttman, MD, PhD, FAAD
Allan C. Halpern, MD, FAAD
Joseph Merola, MD, MSc, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Kenneth J. Tomecki, MD, FAAD
Andrea L. Zaenglein, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Anthony V. Benedetto, DO, FAAD
AbbVie – Investigator(Fees), Stockholder Private Company(Fees); BioDelivery Systems, Inc. – Stockholder(Stock Options); Bristol-Myers Squibb – Stockholder(Stock); Castle Biosciences, Inc – Advisory Board(Honoraria); GSK PLC – Stockholder Private Company(Stock); Haleon PLC – Stockholder Private Company(Stock); Ipsen – Speaker(Honoraria); IQVIA – Investigator(Fees); Organogenesis, Inc. – Speaker/Faculty Education(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees), Speaker(Honoraria), Stockholder(Stock); Stratapharma – Consultant(Honoraria), Investigator(Honoraria), Speaker(Honoraria);
Cheri Frey, MD, FAAD
Aerolase – Speaker/Faculty Education(Honoraria); Avita Medical – Consultant(Honoraria); Benev – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Galderma USA – Speaker(Fees); Kenvue – Advisory Board(Honoraria); La Roche Posay Dermatologique – Advisory Board(Honoraria); Pierre Fabre – Advisory Board(Honoraria); Procter & Gamble Company – Speaker/Faculty Education(Honoraria); Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Unilever – Consultant(Fees);
Emma Guttman, MD, PhD, FAAD
AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees), Consultant(Honoraria); Amgen – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); ASLAN – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Centrexion Therapeutics Corporation – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Connect Biopharma LLC – Consultant(Fees), Consultant(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Fairmount Funds Management LLC – Consultant (1099 relationship)(Fees); Forest Laboratories – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Gate Bioscience – Consultant(Honoraria), Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Google Ventures – Consultant (1099 relationship)(Fees); Horizon Therapeutics USA, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); janssen – Consultant(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Japan Tobacco Inc. – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); JT Central Pharmaceutical Research Institute – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Merck – Consultant(Fees), Consultant(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis Pharmaceuticals Corporation – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Fees); OrbiMed Advisors LLC – Consultant (1099 relationship)(Fees); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Pharmaxis Ltd – Consultant (1099 relationship)(Fees); Pioneering Medicine VII, Inc – Consultant (1099 relationship)(Fees); Pioneering Medicines – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Stockholder(Stock Options); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); RibonTherapeutics, Inc., – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees), Consultant(Honoraria); Schro¨dinger, Inc – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding);
Allan C. Halpern, MD, FAAD
Canfield Scientific, Inc. – Consultant(Other Financial Benefit); SciBASE – Consultant(Other Financial Benefit); SpotDoc – Founder(Other Financial Benefit);
Joseph Merola, MD, MSc, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Fees); Sanofi/Regeneron – Consultant(Honoraria); UCB – Consultant(Honoraria);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Kenneth J. Tomecki, MD, FAAD
No financial relationships exist with ineligible companies.
Andrea L. Zaenglein, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Church & Dwight Co., Inc. – Consultant(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);